Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T06:26:21.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T05:09:56.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T06:50:42.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    The page's study record dates were updated to reflect new postings and milestones: new dates (2026-09-08, 2026-09-02, 2026-08, 2032-11-21) were added and older dates (2025-12-03, 2032-11-30, 2025-12-02, 2025-11) were removed.
    Difference
    0.3%
    Check dated 2026-09-13T01:29:24.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added to the related topics. The site revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.2%
    Check dated 2026-08-29T23:50:00.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a small update to the page content or backend system.
    Difference
    0.0%
    Check dated 2026-08-08T20:14:12.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.